WHO Approves Second Mpox Vaccine for Emergency Use

The World Health Organization (WHO) has granted emergency use approval for a second mpox vaccine from KM Biologics amid concerns over a new virus variant in Africa. In U.S. legal news, a federal judge dismissed Pfizer's attempt to recover $75.2 million from an SEC insider trading settlement, asserting Pfizer did not qualify as a victim. Additionally, a Wyoming judge upheld abortion rights, temporarily blocking strict state abortion bans. Changes in Australia’s immunization reporting will begin on November 16, 2024, as COVID-19 vaccine names will no longer include manufacturer names to streamline data entry. The recent Vaccine Policy Symposium in Texas highlighted rising vaccine hesitancy, with concerns about the political landscape overshadowing public health interests. Finally, the Strategic Advisory Group of Experts on Immunization (SAGE) noted significant global vaccination challenges, with 14.5 million children identified as 'zero-dose' due to immunization gaps exacerbated by the COVID-19 pandemic.